These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 11857669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of sorbitol pathway and treatment effect of aldose reductase inhibitor ONO2235 in the up-regulation of cardiac M2-muscarinic receptors in streptozotocin-induced diabetic rats.
    Liu TP, Juang SW, Cheng JT, Tong YC.
    Neurosci Lett; ; 383(1-2):131-5. PubMed ID: 15936525
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes.
    Kanda M, Eto K, Tanabe N, Sugiyama A, Hashimoto K, Ueno A.
    Jpn J Pharmacol; 1997 Mar; 73(3):221-8. PubMed ID: 9127817
    [Abstract] [Full Text] [Related]

  • 5. Alterations in urinary bladder M2-muscarinic receptor protein and mRNA in 2-week streptozotocin-induced diabetic rats.
    Tong YC, Chin WT, Cheng JT.
    Neurosci Lett; 1999 Dec 31; 277(3):173-6. PubMed ID: 10626841
    [Abstract] [Full Text] [Related]

  • 6. Alteration of M(3) subtype muscarinic receptors in the diabetic rat urinary bladder.
    Tong YC, Cheng JT.
    Pharmacology; 2002 Dec 31; 64(3):148-51. PubMed ID: 11834891
    [Abstract] [Full Text] [Related]

  • 7. Alterations of M(2)-muscarinic receptor protein and mRNA expression in the urothelium and muscle layer of the streptozotocin-induced diabetic rat urinary bladder.
    Tong YC, Cheng JT, Hsu CT.
    Neurosci Lett; 2006 Oct 09; 406(3):216-21. PubMed ID: 16935418
    [Abstract] [Full Text] [Related]

  • 8. Changes of M3-muscarinic receptor protein and mRNA expressions in the bladder urothelium and muscle layer of streptozotocin-induced diabetic rats.
    Cheng JT, Yu BC, Tong YC.
    Neurosci Lett; 2007 Aug 09; 423(1):1-5. PubMed ID: 17630213
    [Abstract] [Full Text] [Related]

  • 9. Effect of epalrestat, an aldose reductase inhibitor, on the generation of oxygen-derived free radicals in neutrophils from streptozotocin-induced diabetic rats.
    Kashima K, Sato N, Sato K, Shimizu H, Mori M.
    Endocrinology; 1998 Aug 09; 139(8):3404-8. PubMed ID: 9681489
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.
    Kikkawa R, Hatanaka I, Yasuda H, Kobayashi N, Shigeta Y, Terashima H, Morimura T, Tsuboshima M.
    Diabetologia; 1983 Apr 09; 24(4):290-2. PubMed ID: 6407887
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats.
    Hotta N, Kakuta H, Fukasawa H, Kimura M, Koh N, Iida M, Terashima H, Morimura T, Sakamoto N.
    Diabetologia; 1985 Mar 09; 28(3):176-80. PubMed ID: 3922829
    [Abstract] [Full Text] [Related]

  • 15. Effects of Ba-Wei-Die-Huang-Wan on the cholinergic function and protein expression of M2 muscarinic receptor of the urinary bladder in diabetic rats.
    Tong YC, Cheng JT, Wan WC.
    Neurosci Lett; 2002 Sep 13; 330(1):21-4. PubMed ID: 12213625
    [Abstract] [Full Text] [Related]

  • 16. Effects of aldose reductase inhibitors on prostacyclin (PGI2) synthesis by aortic rings from rats with streptozotocin-induced diabetes.
    Wakasugi M, Noguchi T, Inoue M, Tawata M, Shindo H, Onaya T.
    Prostaglandins Leukot Essent Fatty Acids; 1991 Dec 13; 44(4):233-6. PubMed ID: 1840007
    [Abstract] [Full Text] [Related]

  • 17. In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor.
    Hotta N, Kakuta H, Koh N, Fukasawa H, Yasuma T, Awaya S, Sakamoto N.
    Diabetes Res Clin Pract; 1991 Oct 13; 14(1):29-35. PubMed ID: 1748061
    [Abstract] [Full Text] [Related]

  • 18. Urinary sorbitol measurement and the effect of an aldose reductase inhibitor on its concentration in the diabetic state.
    Nakano I, Tsugawa T, Shinohara R, Watanabe F, Fujita T, Nagata M, Kato T, Himeno Y, Kobayashi T, Fujiwara K, Nagata M, Itoh M, Nagasaka A.
    J Diabetes Complications; 2003 Oct 13; 17(6):337-42. PubMed ID: 14583178
    [Abstract] [Full Text] [Related]

  • 19. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T, Nishioka H, Yoshioka K, Nakano K, Kondo M, Terashima H.
    Diabetes; 1987 Jan 13; 36(1):6-13. PubMed ID: 3025043
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.